US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Axogen, Inc. - Common Stock (NQ:AXGN)

49.37 -0.26 (-0.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axogen, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Axogen to Participate at Jefferies Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen to Participate at JMP Securities Life Sciences Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. Reports 2023 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
A Preview Of Axogen's Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
From Axogen, Inc.
Via GlobeNewswire
News headline image
Read JMP Securities' Take On Axogen's Interim Update ↗
 
Via Benzinga
News headline image
Axogen Aces Phase 3 Study For Avance Nerve Graft ↗
 
Via Benzinga
News headline image
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including... 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc Reports 2022 Third Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine. 
From Axogen, Inc.
Via GlobeNewswire
News headline image
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
From Axogen, Inc.
Via GlobeNewswire
News headline image
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
News headline image
Axogen: Q2 Earnings Insights ↗
Axogen (NASDAQ:AXGN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher ↗
U.S. stocks remained lower toward the end of trading, with the Nasdaq Composite dropping more than 650 points on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
83 Biggest Movers From Yesterday ↗
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
News headline image
Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points ↗
U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday. 
Via Benzinga
News headline image
57 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >